Michele Callejo
Array BioPharma (United States)(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, Protein Kinase Regulation and GTPase Signaling, Computational Drug Discovery Methods, Synthesis and biological activity, Fluorine in Organic Chemistry
Most-Cited Works
- → Potent and selective pyrazole-based inhibitors of B-Raf kinase(2008)65 cited
- → Non-oxime pyrazole based inhibitors of B-Raf kinase(2010)45 cited
- → Non-oxime inhibitors of B-RafV600E kinase(2010)28 cited
- → Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral Bioavailability(2013)28 cited
- → The Discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors(2010)26 cited
- Abstract #1795: In Vitro and in vivo activity of ARRY-380: A potent, small molecule inhibitor of ErbB2.(2009)
- Abstract #3696: AZD8330 (ARRY-424704): Preclinical evaluation of a potent, selective MEK 1/2 inhibitor currently in phase I trials(2009)
- → ARRY-502: Safety, PK And PD Of The CRTh2 Antagonist In Healthy Subjects Following Repeat Dose Administration(2012)2 cited
- → Abstract 551: A potent and selective cFMS inhibitor regulates the tumor macrophage microenvironment leading to tumor growth inhibition(2011)1 cited
- → 576 POSTER ARRY-768, a highly potent and selective small-molecule PDGFR inhibitor which inhibits cellular and in vivo tumor growth(2008)